Regeneron Pharmaceuticals, Inc. (REGN)
758.00
-6.93
(-0.91%)
USD |
NASDAQ |
Mar 06, 10:17
Regeneron Pharmaceuticals Market Cap : 80.14B for March 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 198.59B |
| Gilead Sciences, Inc. | 178.99B |
| Johnson & Johnson | 570.01B |
| Eli Lilly & Co. | 923.09B |
| Merck & Co., Inc. | 283.31B |
Market Cap Related Metrics
| PE Ratio | 18.24 |
| PS Ratio | 5.741 |
| PEG Ratio | 2.131 |
| Price to Book Value | 2.564 |
| Price to Free Cash Flow | 21.87 |
| Price | 758.00 |
| Earnings Yield | 5.48% |
| PEGY Ratio | 2.020 |
| Operating PE Ratio | 22.24 |
| Normalized PE Ratio | 18.62 |